Market Cap
US$3.4b
Last Updated
2019/10/19 23:35 UTC
Data Sources
Company Financials +
Executive Summary
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide.
Snowflake
Fundamentals
Flawless balance sheet with outstanding track record.
Similar Companies
Share Price & News
How has Exponent's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
-6.8%
EXPO
-0.2%
US Professional Services
0.4%
US Market
1 Year Return
34.4%
EXPO
18.3%
US Professional Services
6.9%
US Market
Return vs Industry: EXPO exceeded the US Professional Services industry which returned 18.3% over the past year.
Return vs Market: EXPO exceeded the US Market which returned 6.9% over the past year.
Shareholder returns
| EXPO | Industry | Market | |
|---|---|---|---|
| 7 Day | -6.8% | -0.2% | 0.4% |
| 30 Day | -8.3% | -0.8% | -1.1% |
| 90 Day | -1.3% | 0.6% | -0.5% |
| 1 Year | 35.9%34.4% | 19.4%18.3% | 9.3%6.9% |
| 3 Year | 140.7%132.7% | 49.4%44.2% | 45.8%36.4% |
| 5 Year | 269.5%247.7% | 84.7%74.9% | 62.9%45.1% |
Price Volatility Vs. Market
How volatile is Exponent's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
The Exponent (NASDAQ:EXPO) Share Price Is Up 287% And Shareholders Are Boasting About It3 weeks ago | Simply Wall St
What To Know Before Buying Exponent, Inc. (NASDAQ:EXPO) For Its Dividend1 month ago | Simply Wall St
A Spotlight On Exponent, Inc.'s (NASDAQ:EXPO) FundamentalsValuation
Is Exponent undervalued compared to its fair value and its price relative to the market?
43.6x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Undervalued: EXPO ($65.63) is trading above our estimate of fair value ($42.39)
Significantly Undervalued: EXPO is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: EXPO is poor value based on its PE Ratio (43.6x) compared to the Professional Services industry average (19.5x).
PE vs Market: EXPO is poor value based on its PE Ratio (43.6x) compared to the US market (17.6x).
Price to Earnings Growth Ratio
Low PEG Ratio: EXPO is poor value based on its PEG Ratio (6.9x)
Price to Book Ratio
PB vs Industry: EXPO is overvalued based on its PB Ratio (9.7x) compared to the US Professional Services industry average (2.4x).
Next Steps
Future Growth
How is Exponent forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
6.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EXPO's forecast earnings growth (6.3% per year) is above the savings rate (2.7%).
Earnings vs Market: EXPO's earnings (6.3% per year) are forecast to grow slower than the US market (14.6% per year).
High Growth Earnings: EXPO's earnings are forecast to grow, but not significantly.
Revenue vs Market: EXPO's revenue (6.4% per year) is forecast to grow slower than the US market (7.2% per year).
High Growth Revenue: EXPO's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: EXPO's Return on Equity is forecast to be high in 3 years time (21.9%)
Next Steps
Past Performance
How has Exponent performed over the past 5 years?
12.7%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: EXPO's earnings have grown by 12.7% per year over the past 5 years.
Accelerating Growth: EXPO's earnings growth over the past year (51.2%) exceeds its 5-year average (12.7% per year).
Earnings vs Industry: EXPO earnings growth over the past year (51.2%) exceeded the Professional Services industry 36.8%.
Return on Equity
High ROE: EXPO's Return on Equity (22.2%) is considered high.
Return on Assets
ROA vs Industry: EXPO has a higher Return on Assets than the Professional Services industry average last year.
Return on Capital Employed
ROCE Improving: EXPO has improved its Return on Capital Employed over the past 3 years.
Next Steps
Financial Health
How is Exponent's financial position?
Financial Position Analysis
Short Term Liabilities: EXPO's short term assets ($351.5M) exceeds its short term liabilities ($99.6M)
Long Term Liabilities: EXPO's short term assets (351.5M) exceeds its long term liabilities (86.2M)
Debt to Equity History and Analysis
Debt Level: EXPO is debt free.
Reducing Debt: EXPO has not had any debt for past 5 years.
Debt Coverage: EXPO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: EXPO has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: EXPO has a low level of unsold assets or inventory.
Debt Coverage by Assets: EXPO's debt is not covered by short term assets (assets are -9.894746151305E+16x debt).
Next Steps
Dividend
What is Exponent's current dividend yield, its reliability and sustainability?
0.97%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: EXPO's dividend (0.98%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.45%).
High Dividend: EXPO's dividend (0.98%) is low compared to the top 25% of dividend payers in the US market (3.73%).
Stable Dividend: Whilst dividend payments have been stable, EXPO has been paying a dividend for less than 10 years.
Growing Dividend: EXPO's dividend payments have increased, but the company has only paid a dividend for 7 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (40.5%), EXPO's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: EXPO's dividends in 3 years are forecast to be well covered by earnings (41.1% payout ratio).
Next Steps
Management
What is the CEO of Exponent's salary, the management and board of directors tenure and is there insider trading?
16.0yrs
Average management tenure
CEO
Catherine Corrigan (50yo)
1.4yrs
Tenure
US$2,143,065
Compensation
Dr. Catherine Ford Corrigan, Ph. D., PE, has been the President of Exponent Inc. since July 29, 2016 and its Chief Executive Officer and Director since May 31, 2018. She served as Group Vice President of T ...
CEO Compensation Analysis
Compensation vs. Market: Catherine has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the US market.
Compensation vs Earnings: Catherine's compensation has been consistent with company performance over the past year.
Management Age and Tenure
16.0yrs
Average Tenure
59yo
Average Age
Experienced Management: EXPO's management team is seasoned and experienced (16 years average tenure).
Board Age and Tenure
2.0yrs
Average Tenure
64yo
Average Age
Experienced Board: EXPO's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: EXPO insiders have only sold shares in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Other Key Executive Group VP & Principal Engineer |
| Shares | 2,000 |
| Max Price | US$70.09 |
| Entity | Individual |
| Shares | 3,000 |
| Max Price | US$70.31 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 1,800 |
| Max Price | US$56.92 |
| Entity | Individual |
| Role | Other Key Executive Group VP & Principal Engineer |
| Shares | 2,366 |
| Max Price | US$56.27 |
| Entity | Individual |
| Shares | 96 |
| Max Price | US$50.92 |
| Entity | Individual |
| Role | Chief Financial Officer Executive VP |
| Shares | 403 |
| Max Price | US$50.92 |
| Entity | Individual |
| Role | Other Key Executive Group VP & Principal Engineer |
| Shares | 66 |
| Max Price | US$50.92 |
| Entity | Individual |
| Role | Other Key Executive Group VP & Principal Engineer |
| Shares | 3,000 |
| Max Price | US$51.50 |
| Entity | Individual |
| Role | Other Key Executive Group VP & Principal Engineer |
| Shares | 7,000 |
| Max Price | US$49.00 |
Ownership Breakdown
Management Team
Richard Schlenker (53yo)
Executive VP
- Tenure: 20.3yrs
- Compensation: US$1.83m
Subbaiah Malladi (72yo)
CTO & Principal Engineer
- Tenure: 21yrs
- Compensation: US$697.53k
Paul Johnston (65yo)
Executive Chairman
- Tenure: 1.4yrs
- Compensation: US$2.43m
Robert Caligiuri (67yo)
Corporate VP of Materials & Corrosion Engineering and Principal Engineer
- Tenure: 29.8yrs
- Compensation: US$393.26k
Sally Shepard (58yo)
Chief Human Resources Officer
- Tenure: 2.5yrs
- Compensation: US$980.14k
Bernard Ross
Co-Founder
- Tenure: 0yrs
Harri Kytomaa (60yo)
Group VP & Principal Engineer
- Tenure: 20.8yrs
- Compensation: US$879.05k
Catherine Corrigan (50yo)
President
- Tenure: 1.4yrs
- Compensation: US$2.14m
Eric Anderson
VP & Corporate Controller
- Tenure: 0yrs
Steven Murray (44yo)
Group VP & Principal Engineer
- Tenure: 11.8yrs
- Compensation: US$1.42m
Board Members
John Shoven (72yo)
Lead Independent Director
- Tenure: 1.4yrs
- Compensation: US$221.58k
Debra Zumwalt (63yo)
Independent Director
- Tenure: 5.4yrs
- Compensation: US$217.83k
Paul Johnston (65yo)
Executive Chairman
- Tenure: 1.4yrs
- Compensation: US$2.43m
Bernard Ross
Co-Founder
- Tenure: 0yrs
Catherine Corrigan (50yo)
President
- Tenure: 1.4yrs
- Compensation: US$2.14m
Carol Lindstrom (65yo)
Independent Director
- Tenure: 2.7yrs
- Compensation: US$205.75k
Karen Richardson (56yo)
Independent Director
- Tenure: 5.8yrs
- Compensation: US$217.83k
Company Information
Exponent, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Exponent, Inc.
- Ticker: EXPO
- Exchange: NasdaqGS
- Founded: 1967
- Industry: Research and Consulting Services
- Sector: Commercial Services
- Market Cap: US$3.407b
- Shares outstanding: 51.92m
- Website: https://www.exponent.com
Number of Employees
Location
- Exponent, Inc.
- 149 Commonwealth Drive
- Menlo Park
- California
- 94025
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| EXPO | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Aug 1990 |
| EP5 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Aug 1990 |
Biography
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory complian ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/19 23:35 |
| End of Day Share Price | 2019/10/18 00:00 |
| Earnings | 2019/09/27 |
| Annual Earnings | 2018/12/28 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.